Scott M. Coiante

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Scott M. Coiante
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Coiante:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Common Stock 145K $534K $3.68 28 Jul 2022 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Financial Officer Restricted Stock Units 481K $322K $0.67 13 Feb 2025 Direct
AGILE THERAPEUTICS INC Chief Financial Officer Common Stock 0 $0 $1.52 26 Aug 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Financial Officer Stock Option (Right to Buy) 721K 13 Feb 2025 Direct
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Stock Option (right to Buy) 89.2K 28 Jul 2022 Direct

Insider Reports Filed by Scott M. Coiante

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 13 Feb 2025 2 $0 4 SVP, Chief Financial Officer 18 Feb 2025, 16:17
LXRX LEXICON PHARMACEUTICALS, INC. 02 Jan 2025 1 $0 4 SVP, Chief Financial Officer 02 Jan 2025, 16:09
LXRX LEXICON PHARMACEUTICALS, INC. 02 Jan 2025 0 $0 3 SVP, Chief Financial Officer 02 Jan 2025, 16:06
AGRX AGILE THERAPEUTICS INC 26 Aug 2024 2 -$30.5K 4 Chief Financial Officer 26 Aug 2024, 17:42
AGRX AGILE THERAPEUTICS INC 03 Oct 2023 1 $0 4 Chief Financial Officer 04 Oct 2023, 16:45
AGRX AGILE THERAPEUTICS INC 16 Aug 2023 0 $0 3 Chief Financial Officer 25 Aug 2023, 17:02
APRE Aprea Therapeutics, Inc. 28 Jul 2022 2 $0 4 SVP, Chief Financial Officer 01 Aug 2022, 17:00
APRE Aprea Therapeutics, Inc. 03 Jun 2022 1 -$28.4K 4 SVP, Chief Financial Officer, Director 07 Jun 2022, 17:02
APRE Aprea Therapeutics, Inc. 10 Mar 2022 2 $0 4 SVP, Chief Financial Officer, Director 14 Mar 2022, 17:02
APRE Aprea Therapeutics, Inc. 25 Feb 2022 1 -$25.8K 4 SVP, Chief Financial Officer 01 Mar 2022, 16:01
APRE Aprea Therapeutics, Inc. 25 Aug 2021 1 -$30K 4 SVP, Chief Financial Officer 27 Aug 2021, 17:01